GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

A Chinese company has developed a new diabetes drug that could become a strong competitor to Ozempic and Monjauro as a weight ...

Doctors are seeing an increase in hair loss among Ozempic users due to the stress of rapid weight loss. The condition is ...

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

In a paper released in Addiction, scientists reported that people with a history of alcohol use disorder who were prescribed ...

Novo Nordisk AS and a group of insurers will pay $32 million to end litigation over its $1.8 billion acquisition of ...

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

Refusing the subscription would be a good test of the friendship. If it continues, your friend is friends with you for who ...